TAK-242 in Patients With Acute Alcoholic Hepatitis

NCT04620148 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute-On-Chronic Liver Failure

Interventions

DRUG: TAK-242
DRUG: Placebo

Sponsor

Akaza Bioscience Ltd

Collaborators

[object Object]